Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology
Reference42 articles.
1. Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1;Achour;Biochem. Biophys. Res. Commun.,2013
2. Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1;Alhosin;Biochem. Pharmacol.,2010
3. Analysis on the regularity of prescription of traditional Chinese medicine for the treatment of prostate cancer;An;Pharmacovigilance in China,2018
4. Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1;Arita;Proc. Natl. Acad. Sci. U. S. A.,2012
5. The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer;Ashraf;Oncotarget,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diosgenin potentiates the anticancer effect of doxorubicin and volasertib via regulating polo-like kinase 1 and triggering apoptosis in hepatocellular carcinoma cells;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-02
2. UPLC-Q-Exactive-MS Combined with Network Pharmacology to Explore the Antitumor Effect of Polygonatum sibiricum Leaf Tea;Journal of Food Biochemistry;2023-12-15
3. Mechanistic insights into UHRF1‑mediated DNA methylation by structure‑based functional clarification of UHRF1 domains (Review);Oncology Letters;2023-11-02
4. Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1;Molecules;2023-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3